Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration

American Journal of Ophthalmology

Volumn 121, Issue 1, 1996, Pages 77-83

  Johnson, L N ^a   Gould, T J ^a   Krohel, G B ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; LEVODOPA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; ISCHEMIA; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VISUAL FIELD;

EID: 0030042490     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)70536-7     Document Type: Article

References (30)

1. LN Johnson AC. Arnold Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy: population-based study in the State of Missouri and Los Angeles County, California J Neuroophthalmol 14 1994 38 44
2. DR Boghen JS. Glaser Ischaemic optic neuropathy: the clinical profile and natural history Brain 98 1975 689 708
3. SS. Hayreh Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management Eye 4 1990 25 41
4. M Beri MR Klugman JA Kohlser SS. Hayreh Anterior ischemic optic neuropathy, VII: incidence of bilaterality and various influencing factors Ophthalmology 94 1987 1020 1028
5. The Ischemic Optic Neuropathy Decompression Trial Study Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful JAMA 273 1995 625 632
6. I Gottlob E. Strangler-Zuschrott Effect of levodopa on contrast sensitivity and scotomas in human amblyopia Invest Ophthalmol Vis Sci 31 1990 776 780
7. LE Leguire GL Rogers DL Bremer P Walson M. Hadjiconstantinou-Neff Levodopa and childhood amblyopia J Pediatr Ophthalmol Strabismus 29 1992 290 298
8. LE Leguire GL Rogers DL Bremer PD Walson ML. McGregor Levodopa/carbidopa for childhood amblyopia Invest Ophthalmol Vis Sci 34 1993 3090 3095
9. I Gottlob J Charlier RD. Reinecke Visual acuities and scotomas after one week levodopa administration in human amblyopia Invest Ophthalmol Vis Sci 33 1992 2722 2728
10. AC Arnold RS. Hepler Natural history of nonarteritic anterior ischemic optic neuropathy J Neuroophthalmol 14 1994 66 69
11. Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics ETDRS report number 7. Ophthalmology 98 1991 741 756
12. LN Johnson A Aminlari JW. Sassani Effect of intermittent versus continuous patient monitoring on reliability indices during automated perimetry Ophthalmology 100 1993 76 84
13. Johnson LN. The relative afferent pupillary defect and visual cortex binocular cell activity: a novel method of fusion recovery with Worth 4-dot test. Arch Ophthalmol Forthcoming.
14. LN. Johnson The effect of light intensity of measurement of the relative afferent pupillary defect Am J Ophthalmol 109 1990 481 482
15. S Kashii M Takahashi M Mandai H Shimizu Y Honda M Sasa Protective action of dopamine against glutamate neurotoxicity in the retina Invest Ophthalmol Vis Sci 35 1994 685 695
16. MBA Djamgoz HJ. Wagner Localization and function of dopamine in the adult vertebrate retina Neurochem Int 20 1992 139 191
17. I. Bodis-Wollner Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients Trends Neurosci 13 1990 296 302
18. C Mora-Ferrer C. Neumeyer Dopamine depletion and wavelength discrimination in goldfish ARVO Abstracts. Invest Ophthalmol Vis Sci 35 4, suppl 1994 1363
19. Johnson LN, Krohel GB, Allen SD, Mozayeni R. Recurrent herpes labialis as a potential risk factor tor nonarteritic anterior ischemic optic neuropathy. J Natl Med Assoc. Forthcoming.
20. LM Schmid MD Calford MGT. Rosa Reorganization of the primary visual cortex (VI) of adult cats occurs immediately following monocular retinal lesions ARVO Abstracts. Invest Ophthalmol Vis Sci 35 4, suppl 1994 1774
21. DH. Hubel Eye, brain and vision 1988 Scientific American Library New York 88 91 137–57, 191–217
22. F. Crick The astonishing hypothesis: the scientific search for the soul 1994 Macmillan Publishing Co. New York 35 57 71–8, 121–59, 177–99, 215–30
23. T. Kasamatsu Enhancement of neuronal plasticity by activating the norepinephrine system in the brain: a remedy for amblyopia Hum Neurobiol 1 1982 49 54
24. T. Kasamatsu Adrenergic regulation of visuocortical plasticity: a role of the locus coeruleus system Prog Brain Res 88 1991 599 616
25. NS Peachey DJ Green H. Ripps Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye Invest Ophthalmol Vis Sci 34 1993 58 65
26. R Iansek D Packham BS Aspey MJG. Harrison An assessment of the possible protective effect of allopurinol in acute stroke J Neurol Neurosurg Psychiatry 49 1986 585 587
27. C Palmer J Towfighi RL Roberts DF. Heitjan Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats Pediatr Res 33 1993 405 411
28. RB Mink M Dutka JM. Hallenbeck Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs Stroke 22 1991 660 665
29. M Faure EA Lissi LA. Videla Antioxidant capacity of allopurinol in biological systems Biochem Int 21 1990 357 366
30. AL Betz J Randall D. Martz Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia Am J Physiol 260 1991 H563 H568